ClinConnect ClinConnect Logo
Search / Trial NCT06284681

Weight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black Adults

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Feb 21, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Weight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black Adults," is studying how different types of health coaching can help improve heart and metabolic health in Black adults who are overweight or have obesity and related health issues like high blood pressure, prediabetes, or high cholesterol. The trial will last for 6 months and involves two main approaches: one that focuses on weight loss and another that does not explicitly aim for weight loss. Participants will be randomly assigned to one of these two groups and will receive health coaching for 7 weeks. After this period, their progress will be assessed to see how well they responded to the coaching. Those who struggle will receive additional support, either through fitness classes or enhanced medical care.

To be eligible for this trial, participants must be at least 18 years old, identify as Black or African American, and have a body mass index (BMI) of 27 or higher along with at least one related health condition. Participants should also have a primary care provider who can help with their care during the study, be comfortable using a device with internet access, and be willing to actively engage in the study. This trial is currently recruiting participants, and the findings will help researchers understand how to better support health improvements in this community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Black or African American Race
  • ≥18 years
  • * BMI ≥27 kg/m2 plus a diagnostic history of 1 or more of the following:
  • Prehypertension or hypertension
  • Prediabetes or type 2 diabetes
  • Dyslipidemia
  • Has a primary care provider who is willing to participate in enhanced medical management condition as needed
  • Access and ability to use a device with reliable internet connectivity
  • Able to converse and read English
  • Willingness to enroll in any possible intervention conditions
  • Willingness to engage in post-intervention focus group
  • Exclusion Criteria:
  • Presence of any condition precluding engagement in the prescribed diet or exercise interventions
  • Currently engaged in a structured lifestyle-based or weight loss intervention

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Patients applied

0 patients applied

Trial Officials

Drew Sayer, PhD

Principal Investigator

University of Alabama at Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported